Operating profit before deduction of amortization: iTeos Therapeutics, Inc. (ITOS)
The EBITDA in monetary terms demonstrates cash flow dynamics, where serves as the base value of the parameter. iTeos Therapeutics management effectively manages capital, ensuring liquidity through a deal with GSK. The environmental development vector includes the modernization of filters and laboratory energy efficiency. However, the absence of commercial products creates a dependency on advances, as operational cash flow is temporarily nonexistent.
iTeos Therapeutics, Inc. (ITOS) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
Debt to Equity Ratio iTeos Therapeutics|ITOS - Long-Term Debt to Capital|Current Liabilities to Capital iTeos Therapeutics Inc|ITOS - Company Aggregate Debts|Debts to Net Assets iTeos Therapeutics|ITOS - Company Long-Term Liabilities|Amount of Current Liabilities iTeos Therapeutics|Immediate Liquidity iteostherapeutics.com
- earnings and multiples data:
ITOS - Company Net Income|Expected Net Profit iTeos Therapeutics|ITOS - Price to Earnings Ratio|Market Cap to Projected Earnings iteostherapeutics.com|ITOS - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation iTeos Therapeutics|ITOS - Operating profit before deduction of amortization|Earnings per share for the last four quarters iTeos Therapeutics|ITOS - Net earnings per share (EPS TTM)|Year-over-year earnings per one share growth for the last 12 months iteostherapeutics.com|ITOS - Earnings growth in current year|Expected net earnings per share growth next year iTeos Therapeutics
Summary company analytics:ITOS iTeos Pharma
iTeos Therapeutics (ITOS) develops advanced immunotherapies to combat oncology by blocking tumor defense mechanisms. The absolute operating profit reflects cash flow before interest and taxes, allowing for an assessment of the business model's resilience and the company's ability to maintain operational efficiency. The stability of this indicator confirms real market demand for innovation, minimizing the risks of a sharp decline in the asset's price.
Competitor analysis for iTeos Therapeutics
Operating income before deduction of amortization argenx BVBA (ARGX)|BNTX - Profit before payment of interest, taxes and amortization|Abivax S.A. (ABVX) - Operating profit before deduction of amortization|ADMA Biologics, Inc. (ADMA) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Protagonist Therapeutics, Inc.|Operating profit before deduction of amortization IMVT|Operating profit EBITDA Kiniksa Corp|Profit before payment of interest, taxes and amortization Grifols, S.A. (GRFS)|adaptivebiotech.com - Operating profit before amortization|Operating profit EBITDA CLDX (Celldex Therapeutics, Inc.)|Aurinia Pharmaceuticals Inc (AUPH) - Profit before interest, taxes and amortization|BioCryst Pharmaceuticals Inc - Operating profit EBITDA|Operating income before deduction of amortization Vera Corp VERA|DNTH (Dianthus Therapeutics) - Operating profit before deduction of amortization|PHVS: Company profit before taxes, interest and amortization|ABCL (AbCellera Biologics Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization Tourmaline Bio Inc TRML|Profit before payment of interest, taxes and amortization Intrexon (PGEN)|PHAR - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Nektar Therapeutics NKTR|Operating income before deduction of amortization upstreambio.com (UPB)|ZBIO: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization IMNM (Immunome Inc)|GOSS (Gossamer Corp) - Operating profit before deduction of amortization|KALV: Company profit before taxes, interest and amortization|SEPN (Septerna Inc) - Operating profit EBITDA|PVLA: Income before deduction of interest, taxes and amortization|Operating profit EBITDA SVRA|RIGL - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization AnaptysBio Corp ANAB|Income before deduction of interest, taxes and amortization ATXS|enGene Holdings Inc. - Operating profit EBITDA|RAPT - Operating profit EBITDA|aerovatetx.com (JBIO) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization ACRS (Aclaris Therapeutics Inc.)|KYTX (Kyverna) - Operating profit EBITDA|Profit before interest, taxes and amortization Tiziana Life Sciences, Ltd. TLSA|Operating profit before deduction of amortization CABA (Cabaletta Bio, Inc.)|Operating profit EBITDA ventyxbio.com (VTYX)|Theratechnologies - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization AVTX (Avalo Therapeutics, Inc.)|Eledon - Operating profit EBITDA|Operating income before deduction of amortization Agenus, Inc AGEN|CLYM: Operating profit EBITDA|Operating profit before deduction of amortization Zura Bio Ltd|Profit before payment of interest, taxes and amortization aTyr Pharma|Adagene Corp (ADAG) - Operating income before deduction of amortization|Operating profit EBITDA IMA|Operating income before deduction of amortization shattucklabs.com|Equillium - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization CNTB (Connect Biopharma Holdings)|IMUX - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Atara Biotherapeutics|inflarx.de (IFRX) - Profit before payment of interest, taxes and amortization|XFOR - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Adicet Bio Inc.|Celularity Corp - Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA INMB|BRNS (Barinthus Biotherapeutics PLC) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA KZR (Kezar Life Sciences, Inc)|Operating profit EBITDA SAB Biotherapeutics Inc SABS|AKTX - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization ENLV (Enlivex Therapeutics)|q32bio.com (QTTB) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization GeoVax Labs|EDSA (Edesa) - Operating profit EBITDA|Operating profit EBITDA iBio Corporation|Operating profit before deduction of amortization CARM (Carisma Therapeutics)|XTLB (xtlbio.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA BOLT (Bolt Biotherapeutics, Inc.)|Operating income before deduction of amortization HCW Biologics, Inc. (HCWB)|APVO - Profit before payment of interest, taxes and amortization|AIM ImmunoTech, Inc. (AIM) - Operating profit before deduction of amortization|aditxt.com (ADTX) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization gribio.com|Operating profit before deduction of amortization XRTX|Operating profit EBITDA Vyome Holdings Inc.|Profit before payment of interest, taxes and amortization Revelation Bio (REVB)|Indaptus Corp - Operating profit before amortization|Operating profit EBITDA SCNI (Scinai Immunotherapeutics)|CalciMedica Inc (CALI) - Profit before interest, taxes and amortization|Affimed Therapeutics - Operating profit EBITDA|Operating income before deduction of amortization Allakos Inc. ALLK|HOOK (hookipapharma.com) - Operating profit before deduction of amortization|IGMS: Company profit before taxes, interest and amortization|OCEA (Ocean Biomedical, Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization tcbiopharm.com TCBP|Profit before payment of interest, taxes and amortization Third Harmonic Bio, Inc. (THRD)
